CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=586483, encodeId=a26a586483d9, content=没有的zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗zyg1 2020-03-12 00:00:00 发表: 您这个悲剧有审稿意见吗, beContent=zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951025, encodeId=32f09510252b, content=请问，这个杂志可以有多个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13315473122, createdName=ms1000001977424574, createdTime=Thu Mar 25 14:19:55 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003674, encodeId=e40e10036e4e3, content=审稿速度:3.0 | 投稿命中率:25.0 | 审稿费用:500.0 | 版面费用:3500.0 偏重的研究方向：癌症 经验分享：大家不要“50步笑百步”了。本期刊因为上海陈竺和张亭栋2001的一篇“AS2O3治疗急性早幼粒细胞白血病”2018获国际大奖“舍贝里奖/瑞典与诺奖平级别”所以国内风向突变，这也有情可原之。cancer research对实验室大数据太过于看重而忽略临床，欧美从1775-2020的245年中尤其是UICC从2016-2018——战胜癌症，We can, I can,2019-2021还不是一夜回到解放前=UICC主题：关爱患者共同抗癌！！！欧美西方除了“乡村医生爱德华詹纳（Edward Jenner）and<The International Council for Harmonisation (ICH)> Good Clinical Practice (GCP) guidelines. 甚至连他写的《小册子》也没有出版社给她发表，可他就在1790年用牛痘消灭‘天花’（没有实验室大数据、没有医学会评估论证、也没有“生命科学研究规则”、更没有<The Declaration of Helsinki>和）...遗憾地是他不是教授也不是院士”...搁在今天也不例外！除此之外欧美日奥加养活了几近一个亿的生物医学家（医生）、伯爵和美国大亨=有什么用处呢？真是...罢罢罢..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800b2444289, createdName=123dfe03m73(暂无昵称), createdTime=Thu Jul 29 20:49:15 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588452, encodeId=f45858845260, content=今年估计能到几分啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586666, encodeId=fbc95866664c, content=另外一篇，也是cr，说的一审大概2-4周。2审1-2周doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, beContent=doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913610, encodeId=c77791361063, content=刚投了一篇……等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Mon Jan 04 15:39:25 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591017, encodeId=993d59101e14, content=请问各位前辈，我的文章现在三审29天后状态变成decision pending 已经5天了，有没有可能拒呢，好紧张！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145679, encodeId=996121456e992, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投过三次，送外审会通知你。 第一次外审1个月，三个审稿人，意见都不乐观，被拒。改投oncogene，中。 第二次外审1个月，三个审稿意见，一个乐观，2个中性，大修后接受，从投稿到接受用了4个月。 第三次，合作文章，并列作者，秒拒。 编辑的态度不错，回复问题很及时。投稿系统bug非常多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:32:39 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128280, encodeId=dbfb212828078, content=请问这个杂质接收以后需要提交原始数据吗？提交什么格式的原始数据呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d5e1735331, createdName=爱的橙子蓝, createdTime=Tue Apr 25 18:42:56 CST 2023, time=2023-04-25, status=1, ipAttribution=天津)]

2020-03-12 西西131401

没有的zyg1 2020-03-12 发表::
您这个悲剧有审稿意见吗zyg1 2020-03-12 00:00:00 发表:
您这个悲剧有审稿意见吗

zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗

74 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=586483, encodeId=a26a586483d9, content=没有的zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗zyg1 2020-03-12 00:00:00 发表: 您这个悲剧有审稿意见吗, beContent=zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951025, encodeId=32f09510252b, content=请问，这个杂志可以有多个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13315473122, createdName=ms1000001977424574, createdTime=Thu Mar 25 14:19:55 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003674, encodeId=e40e10036e4e3, content=审稿速度:3.0 | 投稿命中率:25.0 | 审稿费用:500.0 | 版面费用:3500.0 偏重的研究方向：癌症 经验分享：大家不要“50步笑百步”了。本期刊因为上海陈竺和张亭栋2001的一篇“AS2O3治疗急性早幼粒细胞白血病”2018获国际大奖“舍贝里奖/瑞典与诺奖平级别”所以国内风向突变，这也有情可原之。cancer research对实验室大数据太过于看重而忽略临床，欧美从1775-2020的245年中尤其是UICC从2016-2018——战胜癌症，We can, I can,2019-2021还不是一夜回到解放前=UICC主题：关爱患者共同抗癌！！！欧美西方除了“乡村医生爱德华詹纳（Edward Jenner）and<The International Council for Harmonisation (ICH)> Good Clinical Practice (GCP) guidelines. 甚至连他写的《小册子》也没有出版社给她发表，可他就在1790年用牛痘消灭‘天花’（没有实验室大数据、没有医学会评估论证、也没有“生命科学研究规则”、更没有<The Declaration of Helsinki>和）...遗憾地是他不是教授也不是院士”...搁在今天也不例外！除此之外欧美日奥加养活了几近一个亿的生物医学家（医生）、伯爵和美国大亨=有什么用处呢？真是...罢罢罢..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800b2444289, createdName=123dfe03m73(暂无昵称), createdTime=Thu Jul 29 20:49:15 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588452, encodeId=f45858845260, content=今年估计能到几分啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586666, encodeId=fbc95866664c, content=另外一篇，也是cr，说的一审大概2-4周。2审1-2周doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, beContent=doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913610, encodeId=c77791361063, content=刚投了一篇……等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Mon Jan 04 15:39:25 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591017, encodeId=993d59101e14, content=请问各位前辈，我的文章现在三审29天后状态变成decision pending 已经5天了，有没有可能拒呢，好紧张！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145679, encodeId=996121456e992, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投过三次，送外审会通知你。 第一次外审1个月，三个审稿人，意见都不乐观，被拒。改投oncogene，中。 第二次外审1个月，三个审稿意见，一个乐观，2个中性，大修后接受，从投稿到接受用了4个月。 第三次，合作文章，并列作者，秒拒。 编辑的态度不错，回复问题很及时。投稿系统bug非常多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:32:39 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128280, encodeId=dbfb212828078, content=请问这个杂质接收以后需要提交原始数据吗？提交什么格式的原始数据呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d5e1735331, createdName=爱的橙子蓝, createdTime=Tue Apr 25 18:42:56 CST 2023, time=2023-04-25, status=1, ipAttribution=天津)]

2021-03-25 ms1000001977424574

请问，这个杂志可以有多个通讯作者吗？

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=586483, encodeId=a26a586483d9, content=没有的zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗zyg1 2020-03-12 00:00:00 发表: 您这个悲剧有审稿意见吗, beContent=zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951025, encodeId=32f09510252b, content=请问，这个杂志可以有多个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13315473122, createdName=ms1000001977424574, createdTime=Thu Mar 25 14:19:55 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003674, encodeId=e40e10036e4e3, content=审稿速度:3.0 | 投稿命中率:25.0 | 审稿费用:500.0 | 版面费用:3500.0 偏重的研究方向：癌症 经验分享：大家不要“50步笑百步”了。本期刊因为上海陈竺和张亭栋2001的一篇“AS2O3治疗急性早幼粒细胞白血病”2018获国际大奖“舍贝里奖/瑞典与诺奖平级别”所以国内风向突变，这也有情可原之。cancer research对实验室大数据太过于看重而忽略临床，欧美从1775-2020的245年中尤其是UICC从2016-2018——战胜癌症，We can, I can,2019-2021还不是一夜回到解放前=UICC主题：关爱患者共同抗癌！！！欧美西方除了“乡村医生爱德华詹纳（Edward Jenner）and<The International Council for Harmonisation (ICH)> Good Clinical Practice (GCP) guidelines. 甚至连他写的《小册子》也没有出版社给她发表，可他就在1790年用牛痘消灭‘天花’（没有实验室大数据、没有医学会评估论证、也没有“生命科学研究规则”、更没有<The Declaration of Helsinki>和）...遗憾地是他不是教授也不是院士”...搁在今天也不例外！除此之外欧美日奥加养活了几近一个亿的生物医学家（医生）、伯爵和美国大亨=有什么用处呢？真是...罢罢罢..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800b2444289, createdName=123dfe03m73(暂无昵称), createdTime=Thu Jul 29 20:49:15 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588452, encodeId=f45858845260, content=今年估计能到几分啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586666, encodeId=fbc95866664c, content=另外一篇，也是cr，说的一审大概2-4周。2审1-2周doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, beContent=doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913610, encodeId=c77791361063, content=刚投了一篇……等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Mon Jan 04 15:39:25 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591017, encodeId=993d59101e14, content=请问各位前辈，我的文章现在三审29天后状态变成decision pending 已经5天了，有没有可能拒呢，好紧张！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145679, encodeId=996121456e992, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投过三次，送外审会通知你。 第一次外审1个月，三个审稿人，意见都不乐观，被拒。改投oncogene，中。 第二次外审1个月，三个审稿意见，一个乐观，2个中性，大修后接受，从投稿到接受用了4个月。 第三次，合作文章，并列作者，秒拒。 编辑的态度不错，回复问题很及时。投稿系统bug非常多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:32:39 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128280, encodeId=dbfb212828078, content=请问这个杂质接收以后需要提交原始数据吗？提交什么格式的原始数据呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d5e1735331, createdName=爱的橙子蓝, createdTime=Tue Apr 25 18:42:56 CST 2023, time=2023-04-25, status=1, ipAttribution=天津)]

2021-07-29 123dfe03m73(暂无昵称)

审稿速度:3.0 | 投稿命中率:25.0 | 审稿费用:500.0 | 版面费用:3500.0
偏重的研究方向：癌症
经验分享：大家不要“50步笑百步”了。本期刊因为上海陈竺和张亭栋2001的一篇“AS2O3治疗急性早幼粒细胞白血病”2018获国际大奖“舍贝里奖/瑞典与诺奖平级别”所以国内风向突变，这也有情可原之。cancer research对实验室大数据太过于看重而忽略临床，欧美从1775-2020的245年中尤其是UICC从2016-2018——战胜癌症，We can, I can,2019-2021还不是一夜回到解放前=UICC主题：关爱患者共同抗癌！！！欧美西方除了“乡村医生爱德华詹纳（Edward Jenner）and<The International Council for Harmonisation (ICH)> Good Clinical Practice (GCP) guidelines. 甚至连他写的《小册子》也没有出版社给她发表，可他就在1790年用牛痘消灭‘天花’（没有实验室大数据、没有医学会评估论证、也没有“生命科学研究规则”、更没有<The Declaration of Helsinki>和）...遗憾地是他不是教授也不是院士”...搁在今天也不例外！除此之外欧美日奥加养活了几近一个亿的生物医学家（医生）、伯爵和美国大亨=有什么用处呢？真是...罢罢罢...

49 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=586483, encodeId=a26a586483d9, content=没有的zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗zyg1 2020-03-12 00:00:00 发表: 您这个悲剧有审稿意见吗, beContent=zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951025, encodeId=32f09510252b, content=请问，这个杂志可以有多个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13315473122, createdName=ms1000001977424574, createdTime=Thu Mar 25 14:19:55 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003674, encodeId=e40e10036e4e3, content=审稿速度:3.0 | 投稿命中率:25.0 | 审稿费用:500.0 | 版面费用:3500.0 偏重的研究方向：癌症 经验分享：大家不要“50步笑百步”了。本期刊因为上海陈竺和张亭栋2001的一篇“AS2O3治疗急性早幼粒细胞白血病”2018获国际大奖“舍贝里奖/瑞典与诺奖平级别”所以国内风向突变，这也有情可原之。cancer research对实验室大数据太过于看重而忽略临床，欧美从1775-2020的245年中尤其是UICC从2016-2018——战胜癌症，We can, I can,2019-2021还不是一夜回到解放前=UICC主题：关爱患者共同抗癌！！！欧美西方除了“乡村医生爱德华詹纳（Edward Jenner）and<The International Council for Harmonisation (ICH)> Good Clinical Practice (GCP) guidelines. 甚至连他写的《小册子》也没有出版社给她发表，可他就在1790年用牛痘消灭‘天花’（没有实验室大数据、没有医学会评估论证、也没有“生命科学研究规则”、更没有<The Declaration of Helsinki>和）...遗憾地是他不是教授也不是院士”...搁在今天也不例外！除此之外欧美日奥加养活了几近一个亿的生物医学家（医生）、伯爵和美国大亨=有什么用处呢？真是...罢罢罢..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800b2444289, createdName=123dfe03m73(暂无昵称), createdTime=Thu Jul 29 20:49:15 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588452, encodeId=f45858845260, content=今年估计能到几分啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586666, encodeId=fbc95866664c, content=另外一篇，也是cr，说的一审大概2-4周。2审1-2周doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, beContent=doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913610, encodeId=c77791361063, content=刚投了一篇……等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Mon Jan 04 15:39:25 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591017, encodeId=993d59101e14, content=请问各位前辈，我的文章现在三审29天后状态变成decision pending 已经5天了，有没有可能拒呢，好紧张！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145679, encodeId=996121456e992, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投过三次，送外审会通知你。 第一次外审1个月，三个审稿人，意见都不乐观，被拒。改投oncogene，中。 第二次外审1个月，三个审稿意见，一个乐观，2个中性，大修后接受，从投稿到接受用了4个月。 第三次，合作文章，并列作者，秒拒。 编辑的态度不错，回复问题很及时。投稿系统bug非常多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:32:39 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128280, encodeId=dbfb212828078, content=请问这个杂质接收以后需要提交原始数据吗？提交什么格式的原始数据呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d5e1735331, createdName=爱的橙子蓝, createdTime=Tue Apr 25 18:42:56 CST 2023, time=2023-04-25, status=1, ipAttribution=天津)]

2020-04-08 tomsyu

今年估计能到几分啊？

143 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=586483, encodeId=a26a586483d9, content=没有的zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗zyg1 2020-03-12 00:00:00 发表: 您这个悲剧有审稿意见吗, beContent=zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951025, encodeId=32f09510252b, content=请问，这个杂志可以有多个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13315473122, createdName=ms1000001977424574, createdTime=Thu Mar 25 14:19:55 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003674, encodeId=e40e10036e4e3, content=审稿速度:3.0 | 投稿命中率:25.0 | 审稿费用:500.0 | 版面费用:3500.0 偏重的研究方向：癌症 经验分享：大家不要“50步笑百步”了。本期刊因为上海陈竺和张亭栋2001的一篇“AS2O3治疗急性早幼粒细胞白血病”2018获国际大奖“舍贝里奖/瑞典与诺奖平级别”所以国内风向突变，这也有情可原之。cancer research对实验室大数据太过于看重而忽略临床，欧美从1775-2020的245年中尤其是UICC从2016-2018——战胜癌症，We can, I can,2019-2021还不是一夜回到解放前=UICC主题：关爱患者共同抗癌！！！欧美西方除了“乡村医生爱德华詹纳（Edward Jenner）and<The International Council for Harmonisation (ICH)> Good Clinical Practice (GCP) guidelines. 甚至连他写的《小册子》也没有出版社给她发表，可他就在1790年用牛痘消灭‘天花’（没有实验室大数据、没有医学会评估论证、也没有“生命科学研究规则”、更没有<The Declaration of Helsinki>和）...遗憾地是他不是教授也不是院士”...搁在今天也不例外！除此之外欧美日奥加养活了几近一个亿的生物医学家（医生）、伯爵和美国大亨=有什么用处呢？真是...罢罢罢..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800b2444289, createdName=123dfe03m73(暂无昵称), createdTime=Thu Jul 29 20:49:15 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588452, encodeId=f45858845260, content=今年估计能到几分啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586666, encodeId=fbc95866664c, content=另外一篇，也是cr，说的一审大概2-4周。2审1-2周doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, beContent=doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913610, encodeId=c77791361063, content=刚投了一篇……等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Mon Jan 04 15:39:25 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591017, encodeId=993d59101e14, content=请问各位前辈，我的文章现在三审29天后状态变成decision pending 已经5天了，有没有可能拒呢，好紧张！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145679, encodeId=996121456e992, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投过三次，送外审会通知你。 第一次外审1个月，三个审稿人，意见都不乐观，被拒。改投oncogene，中。 第二次外审1个月，三个审稿意见，一个乐观，2个中性，大修后接受，从投稿到接受用了4个月。 第三次，合作文章，并列作者，秒拒。 编辑的态度不错，回复问题很及时。投稿系统bug非常多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:32:39 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128280, encodeId=dbfb212828078, content=请问这个杂质接收以后需要提交原始数据吗？提交什么格式的原始数据呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d5e1735331, createdName=爱的橙子蓝, createdTime=Tue Apr 25 18:42:56 CST 2023, time=2023-04-25, status=1, ipAttribution=天津)]

2020-03-15 zyg1

另外一篇，也是cr，说的一审大概2-4周。2审1-2周doctor杨 2020-03-11 00:00:00 发表:
我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊

doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊

159 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=586483, encodeId=a26a586483d9, content=没有的zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗zyg1 2020-03-12 00:00:00 发表: 您这个悲剧有审稿意见吗, beContent=zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951025, encodeId=32f09510252b, content=请问，这个杂志可以有多个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13315473122, createdName=ms1000001977424574, createdTime=Thu Mar 25 14:19:55 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003674, encodeId=e40e10036e4e3, content=审稿速度:3.0 | 投稿命中率:25.0 | 审稿费用:500.0 | 版面费用:3500.0 偏重的研究方向：癌症 经验分享：大家不要“50步笑百步”了。本期刊因为上海陈竺和张亭栋2001的一篇“AS2O3治疗急性早幼粒细胞白血病”2018获国际大奖“舍贝里奖/瑞典与诺奖平级别”所以国内风向突变，这也有情可原之。cancer research对实验室大数据太过于看重而忽略临床，欧美从1775-2020的245年中尤其是UICC从2016-2018——战胜癌症，We can, I can,2019-2021还不是一夜回到解放前=UICC主题：关爱患者共同抗癌！！！欧美西方除了“乡村医生爱德华詹纳（Edward Jenner）and<The International Council for Harmonisation (ICH)> Good Clinical Practice (GCP) guidelines. 甚至连他写的《小册子》也没有出版社给她发表，可他就在1790年用牛痘消灭‘天花’（没有实验室大数据、没有医学会评估论证、也没有“生命科学研究规则”、更没有<The Declaration of Helsinki>和）...遗憾地是他不是教授也不是院士”...搁在今天也不例外！除此之外欧美日奥加养活了几近一个亿的生物医学家（医生）、伯爵和美国大亨=有什么用处呢？真是...罢罢罢..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800b2444289, createdName=123dfe03m73(暂无昵称), createdTime=Thu Jul 29 20:49:15 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588452, encodeId=f45858845260, content=今年估计能到几分啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586666, encodeId=fbc95866664c, content=另外一篇，也是cr，说的一审大概2-4周。2审1-2周doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, beContent=doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913610, encodeId=c77791361063, content=刚投了一篇……等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Mon Jan 04 15:39:25 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591017, encodeId=993d59101e14, content=请问各位前辈，我的文章现在三审29天后状态变成decision pending 已经5天了，有没有可能拒呢，好紧张！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145679, encodeId=996121456e992, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投过三次，送外审会通知你。 第一次外审1个月，三个审稿人，意见都不乐观，被拒。改投oncogene，中。 第二次外审1个月，三个审稿意见，一个乐观，2个中性，大修后接受，从投稿到接受用了4个月。 第三次，合作文章，并列作者，秒拒。 编辑的态度不错，回复问题很及时。投稿系统bug非常多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:32:39 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128280, encodeId=dbfb212828078, content=请问这个杂质接收以后需要提交原始数据吗？提交什么格式的原始数据呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d5e1735331, createdName=爱的橙子蓝, createdTime=Tue Apr 25 18:42:56 CST 2023, time=2023-04-25, status=1, ipAttribution=天津)]

2021-01-04 1215c911m91暂无昵称

刚投了一篇……等待中

116 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=586483, encodeId=a26a586483d9, content=没有的zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗zyg1 2020-03-12 00:00:00 发表: 您这个悲剧有审稿意见吗, beContent=zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951025, encodeId=32f09510252b, content=请问，这个杂志可以有多个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13315473122, createdName=ms1000001977424574, createdTime=Thu Mar 25 14:19:55 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003674, encodeId=e40e10036e4e3, content=审稿速度:3.0 | 投稿命中率:25.0 | 审稿费用:500.0 | 版面费用:3500.0 偏重的研究方向：癌症 经验分享：大家不要“50步笑百步”了。本期刊因为上海陈竺和张亭栋2001的一篇“AS2O3治疗急性早幼粒细胞白血病”2018获国际大奖“舍贝里奖/瑞典与诺奖平级别”所以国内风向突变，这也有情可原之。cancer research对实验室大数据太过于看重而忽略临床，欧美从1775-2020的245年中尤其是UICC从2016-2018——战胜癌症，We can, I can,2019-2021还不是一夜回到解放前=UICC主题：关爱患者共同抗癌！！！欧美西方除了“乡村医生爱德华詹纳（Edward Jenner）and<The International Council for Harmonisation (ICH)> Good Clinical Practice (GCP) guidelines. 甚至连他写的《小册子》也没有出版社给她发表，可他就在1790年用牛痘消灭‘天花’（没有实验室大数据、没有医学会评估论证、也没有“生命科学研究规则”、更没有<The Declaration of Helsinki>和）...遗憾地是他不是教授也不是院士”...搁在今天也不例外！除此之外欧美日奥加养活了几近一个亿的生物医学家（医生）、伯爵和美国大亨=有什么用处呢？真是...罢罢罢..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800b2444289, createdName=123dfe03m73(暂无昵称), createdTime=Thu Jul 29 20:49:15 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588452, encodeId=f45858845260, content=今年估计能到几分啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586666, encodeId=fbc95866664c, content=另外一篇，也是cr，说的一审大概2-4周。2审1-2周doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, beContent=doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913610, encodeId=c77791361063, content=刚投了一篇……等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Mon Jan 04 15:39:25 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591017, encodeId=993d59101e14, content=请问各位前辈，我的文章现在三审29天后状态变成decision pending 已经5天了，有没有可能拒呢，好紧张！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145679, encodeId=996121456e992, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投过三次，送外审会通知你。 第一次外审1个月，三个审稿人，意见都不乐观，被拒。改投oncogene，中。 第二次外审1个月，三个审稿意见，一个乐观，2个中性，大修后接受，从投稿到接受用了4个月。 第三次，合作文章，并列作者，秒拒。 编辑的态度不错，回复问题很及时。投稿系统bug非常多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:32:39 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128280, encodeId=dbfb212828078, content=请问这个杂质接收以后需要提交原始数据吗？提交什么格式的原始数据呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d5e1735331, createdName=爱的橙子蓝, createdTime=Tue Apr 25 18:42:56 CST 2023, time=2023-04-25, status=1, ipAttribution=天津)]

2020-05-16 doctor杨

请问各位前辈，我的文章现在三审29天后状态变成decision pending 已经5天了，有没有可能拒呢，好紧张！

104 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=586483, encodeId=a26a586483d9, content=没有的zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗zyg1 2020-03-12 00:00:00 发表: 您这个悲剧有审稿意见吗, beContent=zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951025, encodeId=32f09510252b, content=请问，这个杂志可以有多个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13315473122, createdName=ms1000001977424574, createdTime=Thu Mar 25 14:19:55 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003674, encodeId=e40e10036e4e3, content=审稿速度:3.0 | 投稿命中率:25.0 | 审稿费用:500.0 | 版面费用:3500.0 偏重的研究方向：癌症 经验分享：大家不要“50步笑百步”了。本期刊因为上海陈竺和张亭栋2001的一篇“AS2O3治疗急性早幼粒细胞白血病”2018获国际大奖“舍贝里奖/瑞典与诺奖平级别”所以国内风向突变，这也有情可原之。cancer research对实验室大数据太过于看重而忽略临床，欧美从1775-2020的245年中尤其是UICC从2016-2018——战胜癌症，We can, I can,2019-2021还不是一夜回到解放前=UICC主题：关爱患者共同抗癌！！！欧美西方除了“乡村医生爱德华詹纳（Edward Jenner）and<The International Council for Harmonisation (ICH)> Good Clinical Practice (GCP) guidelines. 甚至连他写的《小册子》也没有出版社给她发表，可他就在1790年用牛痘消灭‘天花’（没有实验室大数据、没有医学会评估论证、也没有“生命科学研究规则”、更没有<The Declaration of Helsinki>和）...遗憾地是他不是教授也不是院士”...搁在今天也不例外！除此之外欧美日奥加养活了几近一个亿的生物医学家（医生）、伯爵和美国大亨=有什么用处呢？真是...罢罢罢..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800b2444289, createdName=123dfe03m73(暂无昵称), createdTime=Thu Jul 29 20:49:15 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588452, encodeId=f45858845260, content=今年估计能到几分啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586666, encodeId=fbc95866664c, content=另外一篇，也是cr，说的一审大概2-4周。2审1-2周doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, beContent=doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913610, encodeId=c77791361063, content=刚投了一篇……等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Mon Jan 04 15:39:25 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591017, encodeId=993d59101e14, content=请问各位前辈，我的文章现在三审29天后状态变成decision pending 已经5天了，有没有可能拒呢，好紧张！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145679, encodeId=996121456e992, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投过三次，送外审会通知你。 第一次外审1个月，三个审稿人，意见都不乐观，被拒。改投oncogene，中。 第二次外审1个月，三个审稿意见，一个乐观，2个中性，大修后接受，从投稿到接受用了4个月。 第三次，合作文章，并列作者，秒拒。 编辑的态度不错，回复问题很及时。投稿系统bug非常多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:32:39 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128280, encodeId=dbfb212828078, content=请问这个杂质接收以后需要提交原始数据吗？提交什么格式的原始数据呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d5e1735331, createdName=爱的橙子蓝, createdTime=Tue Apr 25 18:42:56 CST 2023, time=2023-04-25, status=1, ipAttribution=天津)]

2023-06-30 ms4000000933785288 来自香港

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：投过三次，送外审会通知你。
第一次外审1个月，三个审稿人，意见都不乐观，被拒。改投oncogene，中。
第二次外审1个月，三个审稿意见，一个乐观，2个中性，大修后接受，从投稿到接受用了4个月。
第三次，合作文章，并列作者，秒拒。
编辑的态度不错，回复问题很及时。投稿系统bug非常多！

86 0

[GetPortalCommentsPageByObjectIdResponse(id=586483, encodeId=a26a586483d9, content=没有的zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗zyg1 2020-03-12 00:00:00 发表: 您这个悲剧有审稿意见吗, beContent=zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951025, encodeId=32f09510252b, content=请问，这个杂志可以有多个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13315473122, createdName=ms1000001977424574, createdTime=Thu Mar 25 14:19:55 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003674, encodeId=e40e10036e4e3, content=审稿速度:3.0 | 投稿命中率:25.0 | 审稿费用:500.0 | 版面费用:3500.0 偏重的研究方向：癌症 经验分享：大家不要“50步笑百步”了。本期刊因为上海陈竺和张亭栋2001的一篇“AS2O3治疗急性早幼粒细胞白血病”2018获国际大奖“舍贝里奖/瑞典与诺奖平级别”所以国内风向突变，这也有情可原之。cancer research对实验室大数据太过于看重而忽略临床，欧美从1775-2020的245年中尤其是UICC从2016-2018——战胜癌症，We can, I can,2019-2021还不是一夜回到解放前=UICC主题：关爱患者共同抗癌！！！欧美西方除了“乡村医生爱德华詹纳（Edward Jenner）and<The International Council for Harmonisation (ICH)> Good Clinical Practice (GCP) guidelines. 甚至连他写的《小册子》也没有出版社给她发表，可他就在1790年用牛痘消灭‘天花’（没有实验室大数据、没有医学会评估论证、也没有“生命科学研究规则”、更没有<The Declaration of Helsinki>和）...遗憾地是他不是教授也不是院士”...搁在今天也不例外！除此之外欧美日奥加养活了几近一个亿的生物医学家（医生）、伯爵和美国大亨=有什么用处呢？真是...罢罢罢..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800b2444289, createdName=123dfe03m73(暂无昵称), createdTime=Thu Jul 29 20:49:15 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588452, encodeId=f45858845260, content=今年估计能到几分啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586666, encodeId=fbc95866664c, content=另外一篇，也是cr，说的一审大概2-4周。2审1-2周doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, beContent=doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913610, encodeId=c77791361063, content=刚投了一篇……等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Mon Jan 04 15:39:25 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591017, encodeId=993d59101e14, content=请问各位前辈，我的文章现在三审29天后状态变成decision pending 已经5天了，有没有可能拒呢，好紧张！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145679, encodeId=996121456e992, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投过三次，送外审会通知你。 第一次外审1个月，三个审稿人，意见都不乐观，被拒。改投oncogene，中。 第二次外审1个月，三个审稿意见，一个乐观，2个中性，大修后接受，从投稿到接受用了4个月。 第三次，合作文章，并列作者，秒拒。 编辑的态度不错，回复问题很及时。投稿系统bug非常多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:32:39 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128280, encodeId=dbfb212828078, content=请问这个杂质接收以后需要提交原始数据吗？提交什么格式的原始数据呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d5e1735331, createdName=爱的橙子蓝, createdTime=Tue Apr 25 18:42:56 CST 2023, time=2023-04-25, status=1, ipAttribution=天津)]

2023-06-18 ms2000000311873048 来自湖南省

审稿速度:1.0
偏重的研究方向：肿瘤
经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧

82 0

[GetPortalCommentsPageByObjectIdResponse(id=586483, encodeId=a26a586483d9, content=没有的zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗zyg1 2020-03-12 00:00:00 发表: 您这个悲剧有审稿意见吗, beContent=zyg1 2020-03-12 发表:: 您这个悲剧有审稿意见吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJFrt3WdV0nESgrJiaELZI7Xj0uNOFjt052Thc8Aomg4thuSWnkyzaZYqIJhPLkIgWaIbswDxUW2sg/132, createdBy=608d1996208, createdName=西西131401, createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951025, encodeId=32f09510252b, content=请问，这个杂志可以有多个通讯作者吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13315473122, createdName=ms1000001977424574, createdTime=Thu Mar 25 14:19:55 CST 2021, time=2021-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003674, encodeId=e40e10036e4e3, content=审稿速度:3.0 | 投稿命中率:25.0 | 审稿费用:500.0 | 版面费用:3500.0 偏重的研究方向：癌症 经验分享：大家不要“50步笑百步”了。本期刊因为上海陈竺和张亭栋2001的一篇“AS2O3治疗急性早幼粒细胞白血病”2018获国际大奖“舍贝里奖/瑞典与诺奖平级别”所以国内风向突变，这也有情可原之。cancer research对实验室大数据太过于看重而忽略临床，欧美从1775-2020的245年中尤其是UICC从2016-2018——战胜癌症，We can, I can,2019-2021还不是一夜回到解放前=UICC主题：关爱患者共同抗癌！！！欧美西方除了“乡村医生爱德华詹纳（Edward Jenner）and<The International Council for Harmonisation (ICH)> Good Clinical Practice (GCP) guidelines. 甚至连他写的《小册子》也没有出版社给她发表，可他就在1790年用牛痘消灭‘天花’（没有实验室大数据、没有医学会评估论证、也没有“生命科学研究规则”、更没有<The Declaration of Helsinki>和）...遗憾地是他不是教授也不是院士”...搁在今天也不例外！除此之外欧美日奥加养活了几近一个亿的生物医学家（医生）、伯爵和美国大亨=有什么用处呢？真是...罢罢罢..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=800b2444289, createdName=123dfe03m73(暂无昵称), createdTime=Thu Jul 29 20:49:15 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588452, encodeId=f45858845260, content=今年估计能到几分啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586666, encodeId=fbc95866664c, content=另外一篇，也是cr，说的一审大概2-4周。2审1-2周doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, beContent=doctor杨 2020-03-11 00:00:00 发表: 我也是正在二审underreview，已经20多天了，我看平均得1个月吧，希望别拒啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e651997208, createdName=zyg1, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913610, encodeId=c77791361063, content=刚投了一篇……等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Mon Jan 04 15:39:25 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591017, encodeId=993d59101e14, content=请问各位前辈，我的文章现在三审29天后状态变成decision pending 已经5天了，有没有可能拒呢，好紧张！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101b2012641, createdName=doctor杨, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145679, encodeId=996121456e992, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投过三次，送外审会通知你。 第一次外审1个月，三个审稿人，意见都不乐观，被拒。改投oncogene，中。 第二次外审1个月，三个审稿意见，一个乐观，2个中性，大修后接受，从投稿到接受用了4个月。 第三次，合作文章，并列作者，秒拒。 编辑的态度不错，回复问题很及时。投稿系统bug非常多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd8b8736567, createdName=ms4000000933785288, createdTime=Fri Jun 30 16:32:39 CST 2023, time=2023-06-30, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128280, encodeId=dbfb212828078, content=请问这个杂质接收以后需要提交原始数据吗？提交什么格式的原始数据呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7d5e1735331, createdName=爱的橙子蓝, createdTime=Tue Apr 25 18:42:56 CST 2023, time=2023-04-25, status=1, ipAttribution=天津)]

2023-04-25 爱的橙子蓝来自天津

请问这个杂质接收以后需要提交原始数据吗？提交什么格式的原始数据呀

78 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务